Healthcare provider profile · identity verified

Kelli Linick, MD

Family Practice · BEDFORD, VA · NPI 1851364756

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	438	124
Lisinopril	Lisinopril	332	97
Amlodipine Besylate	Amlodipine Besylate	289	88
Levothyroxine Sodium	Levothyroxine Sodium	266	73
Rosuvastatin Calcium	Rosuvastatin Calcium	229	71
Gabapentin	Gabapentin	196	53
Metformin Hcl	Metformin Hcl	189	56
Losartan Potassium	Losartan Potassium	174	56
Simvastatin	Simvastatin	166	46
Metoprolol Succinate	Metoprolol Succinate	158	42
Albuterol Sulfate Hfa	Albuterol Sulfate	146	41
Hydrochlorothiazide	Hydrochlorothiazide	136	41
Omeprazole	Omeprazole	136	40
Pantoprazole Sodium	Pantoprazole Sodium	136	40
Furosemide	Furosemide	118	41
Metoprolol Tartrate	Metoprolol Tartrate	117	39
Sertraline Hcl	Sertraline Hcl	100	32
Clopidogrel	Clopidogrel Bisulfate	94	26
Tamsulosin Hcl	Tamsulosin Hcl	94	26
Pravastatin Sodium	Pravastatin Sodium	93	30
Duloxetine Hcl	Duloxetine Hcl	91	23
Jardiance	Empagliflozin	91	20
Allopurinol	Allopurinol	90	26
Eliquis	Apixaban	84	24
Trazodone Hcl	Trazodone Hcl	81	25
Escitalopram Oxalate	Escitalopram Oxalate	78	21
Metformin Hcl Er	Metformin Hcl	78	21
Potassium Chloride	Potassium Chloride	77	24
Montelukast Sodium	Montelukast Sodium	74	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	23
Alprazolam	Alprazolam	67	suppressed
Tramadol Hcl	Tramadol Hcl	66	19
Carvedilol	Carvedilol	65	20
Alendronate Sodium	Alendronate Sodium	61	16
Pioglitazone Hcl	Pioglitazone Hcl	61	19
Breo Ellipta	Fluticasone/Vilanterol	56	suppressed
Prednisone	Prednisone	55	51
Donepezil Hcl	Donepezil Hcl	54	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	15
Chlorthalidone	Chlorthalidone	50	16
Fluoxetine Hcl	Fluoxetine Hcl	50	15
Spironolactone	Spironolactone	50	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	17
Valsartan	Valsartan	48	13
Famotidine	Famotidine	47	12
Glipizide	Glipizide	47	15
Meloxicam	Meloxicam	47	15
Cephalexin	Cephalexin	44	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	14
Baclofen	Baclofen	43	11
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Atenolol	Atenolol	42	13
Finasteride	Finasteride	40	suppressed
Mirtazapine	Mirtazapine	39	13
Glimepiride	Glimepiride	38	11
Amoxicillin	Amoxicillin	37	23
Esomeprazole Magnesium	Esomeprazole Magnesium	37	11
Fluticasone Propionate	Fluticasone Propionate	37	19
Glipizide Er	Glipizide	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Nystatin	Nystatin	34	17
Tizanidine Hcl	Tizanidine Hcl	34	13
Bupropion Xl	Bupropion Hcl	33	11
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Ezetimibe	Ezetimibe	32	11
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Klor-Con M10	Potassium Chloride	32	12
Lorazepam	Lorazepam	32	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Ondansetron Odt	Ondansetron	28	12
Warfarin Sodium	Warfarin Sodium	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Diazepam	Diazepam	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Ozempic	Semaglutide	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	12
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Mupirocin	Mupirocin	17	15
Nifedipine Er	Nifedipine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	11
Repatha Sureclick	Evolocumab	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Colchicine	Colchicine	14	suppressed
Glycopyrrolate	Glycopyrrolate	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Naproxen	Naproxen	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Singulair	Montelukast Sodium	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Ramipril	Ramipril	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error